Clinical trials · New York
Cancer clinical trials in New York
We’re tracking 1,365 recruiting cancer studies with a site in New York — including Early Phase 1, Phase 1, Phase 1/Phase 2, Phase 2 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies in New York
- NCT05954832Recruiting
Monitoring heart function and blood flow during general anesthesia
This study checks how heart function and blood flow change in adults while they receive general anesthesia for surgery. It may help doctors better understand what happens to the heart during anesthesia and adjust care for safety.
New York, New YorkAges 18 years+ - NCT07446855RecruitingPhase 1/Phase 2
Study of AZD4956 for advanced solid tumors with DNA repair problems
This trial tests a new drug called AZD4956, alone or with other cancer medicines, for people with advanced solid tumors that have certain DNA repair problems (called homologous recombination deficiency). It may be an option if you have breast, ovarian, prostate, or pancreatic cancer with a specific gene change, and you have or haven't had previous PARP inhibitor treatment.
New York, New YorkAges 18–130 - NCT06126276RecruitingPhase 2
Testing neratinib with or without palbociclib for HER2+ solid tumors
This trial tests two targeted drugs—neratinib alone or with palbociclib—for people with HER2-positive solid tumors (other than breast cancer) that have returned or not gone away. The goal is to see if blocking HER2 and CDK4/6 can shrink or slow the tumor.
Buffalo, New YorkAges 18 years+ - NCT06306638RecruitingPhase 1/Phase 2
Light therapy after radiation for inoperable airway tumors
This trial tests a new light-activated therapy (interstitial photodynamic therapy) after palliative radiation to shrink inoperable airway tumors and improve breathing. It is for people with solid cancers that block the airway from the outside and cannot be removed with surgery.
Buffalo, New YorkAges 18 years+ - NCT04142437Recruiting
Tracking how larotrectinib works for NTRK fusion cancers in routine care
This study follows people with cancers that have an NTRK gene fusion to learn how safe and effective larotrectinib is during everyday treatment. It may help confirm whether this medicine works well in real-world patients and side effects stay manageable.
Buffalo, New YorkAges Any age - NCT06816459RecruitingEarly Phase 1
Scent tests to find flavors in menthol cigarettes
This study tests if adult menthol cigarette smokers can identify different flavors by smell. You will complete a simple smell test and then try different cigarettes to see if you can tell flavors apart.
Buffalo, New YorkAges 21–55 - NCT06843434RecruitingPhase 2
Study of two immunotherapy drugs for rectal cancer
This trial tests a combination of two immunotherapy drugs, botensilimab and balstilimab, for people with newly diagnosed rectal adenocarcinoma that has not spread. The goal is to see if this treatment can shrink the tumor before surgery.
Commack, New YorkAges 18 years+ - NCT07192432RecruitingPhase 1/Phase 2
Gene therapy for HER2-positive cancer
This trial tests a new gene therapy for people with HER2-positive cancer. It is for two groups: those with advanced cancer that has worsened after treatment, and those with early-stage cancer at high risk of coming back. The goal is to see if the therapy can safely help shrink tumors or prevent return.
New York, New YorkAges 18 years+ - NCT04548817Recruiting
Registry for neurocutaneous and brain melanocytosis
This trial is a registry that collects information from people with certain pigment-related conditions affecting the skin and/or the brain. It helps doctors better understand the condition and may improve future care.
New York, New YorkAges Any age - NCT06594991RecruitingPhase 2
A study of three immunotherapy drugs for advanced melanoma
This trial tests a combination of three immunotherapy drugs (fianlimab, cemiplimab, and ipilimumab) for people with advanced melanoma that has stopped responding to previous PD-1/PD-L1 treatment. It aims to see if this new combination can help shrink or control the cancer.
Uniondale, New YorkAges 18 years+ - NCT07082868RecruitingPhase 1
Study of epcoritamab and ibrutinib for central nervous system lymphoma
This trial tests a combination of two drugs, epcoritamab and ibrutinib, for people whose lymphoma has come back or not responded to treatment and has spread to the brain or spinal cord. The goal is to see if this combination can help control the disease.
Commack, New YorkAges 18 years+ - NCT05815173RecruitingPhase 1
Ladarixin plus sotorasib for KRAS-mutated lung cancer
This Phase 1 trial tests whether ladarixin combined with sotorasib can help people with advanced or metastatic non-small cell lung cancer (NSCLC) that has a KRAS G12C mutation. It’s mainly testing safety and how well the treatments work after the cancer has progressed despite prior anti–PD-1 treatment.
Garden City, New YorkAges 18–100 - NCT07024615RecruitingPhase 1
Study of ASP2138 before surgery for pancreatic cancer
This study tests an experimental drug, ASP2138, given before surgery for pancreatic cancer that is still removable. After surgery, you will receive standard chemotherapy. The goal is to see if adding ASP2138 before surgery helps improve outcomes.
New York, New YorkAges 18 years+ - NCT05939414RecruitingPhase 3
Lutetium prostate cancer treatment for limited PSMA-spread
This Phase 3 trial compares a targeted radiation medicine called lutetium (177Lu) vipivotide tetraxetan versus watchful waiting in people with prostate cancer that has spread to only a few spots. The goal is to see if the treatment can better control the cancer when scans show a small amount of PSMA-positive metastases.
New York, New YorkAges 18–100 - NCT05008848RecruitingPhase 3
Text message program to help rural cancer survivors quit smoking
This trial studies a text-message based program to help people who smoke quit. It targets adults in rural areas who are currently in cancer treatment and want support stopping smoking.
Cooperstown, New YorkAges 18 years+ - NCT07619079Recruiting
Registry study of early colorectal cancer in polyps
This study collects information from patients who had a polyp removed from their colon that contained early-stage cancer. Researchers want to understand how these polyps are best managed and what happens to patients over time.
Commack, New YorkAges 18 years+ - NCT05641831RecruitingPhase 2
Canakinumab to prevent clonal blood count problems turning into cancer
This Phase 2 study tests canakinumab to help stop high-risk clonal cytopenias of unknown significance (CCUS) from progressing into a blood cancer. If you have persistent low blood counts and specific genetic features, this treatment may lower the chance of progression.
New York, New YorkAges 18 years+ - NCT06693700Recruiting
Using an air quality monitor to help make your home smoke-free
This study tests whether an indoor air quality monitor can help people keep their homes smoke-free. It is for MSK patients who currently smoke and want to reduce smoke exposure indoors.
New York, New YorkAges 18 years+ - NCT07393529Recruiting
Social support program for older adults with advanced cancer
This study tests a special program that helps older adults with advanced cancer get support from their friends and family. If you join, you might be assigned to a group that receives this social network support or a group that gets the usual care. The goal is to see if having your loved ones more involved improves your quality of life.
Rochester, New YorkAges 65 years+ - NCT05985148RecruitingPhase 1
Radiosurgery for chronic chest or stomach wall pain
This trial tests whether a precise, one-time radiation treatment (stereotactic radiosurgery) can relieve long-term pain in the chest or stomach wall. It may be an option for people whose pain is not well controlled with standard pain medicines.
Uniondale, New YorkAges 18 years+ - NCT06513962RecruitingPhase 3
Triptorelin to protect ovaries in young women with cancer
This study tests whether a medicine called triptorelin can protect the ovaries in young women and teens receiving strong chemotherapy for cancer. If you are newly diagnosed with a cancer (other than breast cancer) and are about to get certain chemotherapy drugs, this trial may help preserve your fertility.
Albany, New YorkAges Up to 39 years - NCT05865535RecruitingPhase 1
Dose study of AV-380 for cancer-related weight loss
This Phase 1 trial tests a new drug (AV-380) in people with solid tumor cancer who are losing weight and muscle because of cancer. It mainly helps researchers find a safe dose and see how the body responds, and it may offer a new option for cancer-related cachexia.
Shirley, New YorkAges 18 years+ - NCT06295952RecruitingPhase 2
Study of Pasireotide for Prolactinoma
This trial tests a drug called pasireotide for people with prolactinoma (a type of pituitary tumor) who cannot use standard dopamine agonist medicines or whose tumors do not shrink enough with them. It may be an option if surgery isn't right for you.
Uniondale, New YorkAges 18 years+ - NCT06411821RecruitingPhase 2
Ulixertinib for people with histiocytic neoplasms
This trial tests an oral targeted therapy called ulixertinib for people with histiocytic neoplasms (a rare group of blood cell disorders). It aims to see if the drug can shrink tumors or control the disease in patients who have not responded to other treatments.
Uniondale, New YorkAges 12 years+
Cancer trials by city in New York
Where these studies are running in New York
Institutions with a site for the recruiting cancer studies listed above.
- Memorial Sloan Kettering Cancer Center · 15 studies
- Memorial Sloan Kettering Commack · 8 studies
- Memorial Sloan Kettering Nassau · 8 studies
- Memorial Sloan Kettering Westchester · 6 studies
- Roswell Park Cancer Institute · 3 studies
- Memorial Sloan Kettering Cancer Center - Westchester · 2 studies
- University of Rochester · 2 studies
- Weill Cornell Medicine · 2 studies
What taking part in a cancer study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Cancer trials in other states
Common questions
- Are there cancer clinical trials in New York?
- Yes. We're currently tracking 1,365 recruiting cancer studies with a site in New York, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a cancer study in New York?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in New York to take part?
- Not necessarily. These studies have a site in New York, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a cancer trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New cancer studies open in New York regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.